Glasier, Anna Edelman, Alison Creinin, Mitchell D Brache, Vivian Westhoff, Carolyn L Han, Leo Chen, Melissa J Hemon, Agnes
ObjectivesTo estimate the effects on cervical mucus, ovarian activity and theoretical contraceptive protection of a 6-hour delay and of missing one norgestrel 0.075 mg progestogen-only pill.Study designIn a prospective, two-site, randomized, crossover study, healthy women aged 18 to 35 with BMI
Townsend, MS Ontai, L Ritchie, L Williams, S Young, T
Kaunitz, Andrew M Achilles, Sharon L Zatik, János Weyers, Steven Piltonen, Terhi Suturina, Larisa Apolikhina, Inna Bouchard, Celine Chen, Melissa J Jensen, Jeffrey T
...
ObjectiveTo evaluate the bleeding patterns of a new combined oral contraceptive containing estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg in a 24/4-day regimen.Study designWe pooled bleeding data from two parallel, open-label, 13-cycle phase 3 trials that enrolled participants 16 to 50 years old with body mass index (BMI) ≤35 kg/m2. Participants repo...
Pagano, Livio Salmanton-García, Jon Marchesi, Francesco Blennow, Ola Gomes da Silva, Maria Glenthøj, Andreas van Doesum, Jaap Bilgin, Yavuz M López-García, Alberto Itri, Federico
...
Limited data are available on breakthrough COVID-19 in patients with hematologic malignancy (HM) after anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. Adult patients with HM, ≥1 dose of anti-SARS-CoV-2 vaccine, and breakthrough COVID-19 between January 2021 and March 2022 were analyzed. A total of 1548 cases were incl...
Creinin, Mitchell D Schreiber, Courtney A Turok, David K Cwiak, Carrie Chen, Beatrice A Olariu, Andrea I
BackgroundExtending hormonal intrauterine system duration will allow users to have less need for procedures to provide long-term contraception.ObjectiveThis study aimed to evaluate the efficacy and safety of the levonorgestrel 52 mg intrauterine system during years 7 and 8 of use.Study designA total of 1751 nulliparous and multiparous participants ...
Chen, Melissa J Jensen, Jeffrey T Kaunitz, Andrew M Achilles, Sharon L Zatik, János Weyers, Steven Piltonen, Terhi Suturina, Larisa Apolikhina, Inna Bouchard, Celine
...
ObjectivesTo evaluate tolerability and safety of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg oral contraceptive using pooled data from two, multicenter, phase 3 trials.Study designThe two trials enrolled participants aged 16-50 years with a body mass index ≤35.0 kg/m2 to use E4/DRSP in a 24/4-day regimen for up to 13 cycles. We pooled data from pa...
Liang, Su-Ying Richardson, Michael T Wong, Deanna Chen, Tony Colocci, Natalia Kapp, Daniel S de Bruin, Monique Kurian, Allison Chan, John K
Older patients and those who require interpreters are least likely to use telehealth for gynecologic oncology care, showing disparities which continued after statewide vaccinations.
Bai, Jin Lechuga, Thomas J Makhoul, Joshua Yan, Hao Major, Carol Hameed, Afshan Chen, Dongbao
Elevated endogenous estrogens stimulate human uterine artery endothelial cell (hUAEC) hydrogen sulfide (H2S) production by selectively upregulating the expression of H2S synthesizing enzyme cystathionine β-synthase (CBS), but the underlying mechanisms are underdetermined. We hypothesized that CBS transcription mediates estrogen-stimulated pregnancy...
Jensen, Jeffrey T Kaunitz, Andrew M Achilles, Sharon L Zatik, János Weyers, Steven Piltonen, Terhi Suturina, Larisa Apolikhina, Inna Bouchard, Céline Chen, Melissa J
...
ObjectiveTo evaluate overall and subgroup efficacy of an estetrol (E4) 15 mg drospirenone (DRSP) 3 mg oral contraceptive in a 24/4-day regimen.Study designWe pooled efficacy outcomes from 2 pivotal phase 3 contraceptive trials with E4/DRSP conducted in the United States/Canada and Europe/Russia. We assessed Pearl Index (PI; pregnancies per 100 part...
Miller, Paul Lei, Li Charu, Vivek Higgins, John Troxell, Megan Kambham, Neeraja
BackgroundMembranous nephropathy is an uncommon cause of nephrotic syndrome in pediatrics.MethodsWe reviewed our kidney biopsy records for patients ≤ 20 years of age with membranous nephropathy without evidence of systemic lupus erythematosus within 6 months of biopsy (January 1995-September 2020). Staining for PLA2R, NELL1, THSD7A, SEMA3B, EXT2 (3...